Effect of Low-Dose Caffeine on Performance in Elite Sitting Volleyball Players

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

13 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-03-05

Study Completion Date

2025-03-12

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Background: Sitting volleyball is a sport that relies primarily on upper body strength and anaerobic capacity. In critical in-game skills such as serve and spike, factors such as speed-endurance time and impact power play a decisive role in performance. There are limited studies in the literature examining the effects of low-dose caffeine consumption on these skills. The effects of ergogenic supplements in Paralympic sports have not been sufficiently investigated, and the potential benefits of caffeine on serve and spike performance in sitting volleyball players remain unclear. Purpose: The main purpose of this research was to determine the effects of low-dose caffeine (3 mg/kg) consumption on the serve speed, spike speed and Speed-Endurance performances of elite-level sitting volleyball players. Method: The study was designed using a randomized, double-blind, balanced, and crossover experimental design. 13 elite male athletes from the 2024 Paravolley European Champion Sitting Volleyball Men's National Team participated in the study. Participants were evaluated for serve speed, spike speed, and speed-endurance performances in both 3 mg/kg caffeine (CAF) and placebo (PLA) conditions.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Effect of Caffeinated Chewing Gum on Vertical Jump Performance in Female Volleyball Players

NCT07240506

Athletic Performance

COMPLETED NA

Effects of Caffeine on Upper Extremity Performance

NCT05916352

Sportive Performance Caffeine

COMPLETED NA

The Acute Effects of Combined Caffeine and Sodium Bicarbonate Consumption on Isometric Mid-thigh Pull

NCT05883046

Athletes

COMPLETED NA

The Relationship Between Upper Extremity Explosive Power and Trunk Muscles in Volleyball Players

NCT06001242

Ultrasonography Upper Extremity Physical Endurance

UNKNOWN

Respiration and Balance in Adolescent Volleyball Players

NCT06979349

Adolescent Behavior Athletic Injuries

RECRUITING

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This study aimed to investigate the effects of low-dose caffeine ingestion on key performance parameters in elite-level sitting volleyball athletes. Sitting volleyball is a Paralympic sport that relies heavily on upper body explosive strength and short-term anaerobic power. While caffeine is a well-known ergogenic aid in able-bodied sports, its role in Paralympic contexts remains underexplored. Using a randomized, double-blind, placebo-controlled crossover design, the effects of 3 mg/kg caffeine consumption were assessed in 13 elite male sitting volleyball players. Each participant completed performance assessments under both caffeine and placebo conditions. The primary goal was to examine whether caffeine intake would enhance serve speed, spike speed, and repeated sprint ability. The study provides new insights into the acute ergogenic effects of caffeine in Paralympic team sport athletes, highlighting its selective benefit on explosive upper-body tasks such as serving.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Caffeine Physical Endurance Muscle Strength Paralympic Athletes

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

QUADRUPLE

Participants Caregivers Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Low-Dose Caffeine Arm

Participants receive a single oral dose of caffeine (3 mg/kg) during the first session and a placebo in the second session. There is a washout period of at least 48 hours between sessions.

Group Type EXPERIMENTAL